$DVAX Headlines Ascena Retail shares rally after hours

New Post Public Reply Private Reply Replies (0) Message Board

Dec 27, 2013 at 9:49 AM

$DVAX Headlines

Ascena Retail shares rally after hours 4:50 p.m. Sept. 24, 2013 - Wallace Witkowski
FDA: Dynavax hep B vaccine needs more evaluation 6:49 a.m. Feb. 25, 2013 - MarketWatch.com
Dynavax Tech down 14% in premarket 7:51 a.m. Dec. 3, 2012 - Steve Gelsi
Dynavax Tech off 17% in premarket trades 7:38 a.m. Nov. 29, 2012 - Steve Gelsi
Dynavax Tech falls 49% in premarket trades 8:42 a.m. Nov. 16, 2012 - Steve Gelsi
Wednesday’s biggest gaining and declining stocks 1:42 p.m. May 9, 2012 - MarketWatch
Dynavax tumbles 24% on stock offer pricing 11:05 a.m. May 9, 2012 - Val Brickates Kennedy
Dynavax jumps 25% on FDA update 8:45 a.m. July 28, 2011 - Val Brickates Kennedy
Dynavax plunges 16% on mixed study results 10:26 a.m. July 20, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:57 p.m. Sept. 21, 2010 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:43 p.m. Nov. 10, 2009 - MarketWatch
Dynavax to buy Symphony Dynamo 7:00 a.m. Nov. 10, 2009 - William L. Watts
Symphony to own 24% of Dynavax 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to issue 13 million shares 6:49 a.m. Nov. 10, 2009 - Steve Goldstein
Dynavax to buy Symphony Dynamo 6:48 a.m. Nov. 10, 2009 - Steve Goldstein
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Dynavax retrenches; drug stocks mixed 1:18 p.m. Sept. 11, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy

Dynavax Submits Response to EMA - Analyst Blog 12:10 p.m. Dec. 24, 2013 - Zacks.com
Make Or Break Catalysts Approaching For Dynavax 8:28 a.m. Dec. 24, 2013 - Seeking Alpha
Dynavax: Embarking On A Run Propelled By 2 Potential Approvals 3:33 a.m. Dec. 19, 2013 - Seeking Alpha
Dynavax Technologies (DVAX) Catches Eye: Stock Rises 5.2% - Tale of the Tape 9:18 a.m. Nov. 25, 2013 - Zacks.com
Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape 9:18 a.m. Nov. 20, 2013 - Zacks.com
Getting Ultra-Bullish On Dynavax 6:56 a.m. Nov. 18, 2013 - Seeking Alpha
Dynavax Technologies: 6 Reasons To Buy 11:24 a.m. Nov. 17, 2013 - Seeking Alpha
Insiders Are Buying These Speculative Biotech Stocks 10:05 a.m. Nov. 11, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 Safety Trial 7:44 a.m. Nov. 8, 2013 - benzinga.com
Top Three Largest Insider Buys of the Past Week 4:41 p.m. Nov. 5, 2013 - GuruFocus.com
AGCO Corporation Director Buys 343K Shares and 4 Insider Buys to Note 8:10 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Insiders Are Buying Dynavax 3:11 p.m. Oct. 31, 2013 - Seeking Alpha
Dynavax: New Phase 3 Clinical Study Finalized For HEPLISAV 4:00 a.m. Oct. 17, 2013 - Seeking Alpha
Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow 3:11 p.m. Oct. 16, 2013 - benzinga.com
Pipeline Progress at Dynavax - Analyst Blog 11:10 a.m. Oct. 15, 2013 - Zacks.com
Dynavax Initiates Phase I Trial In Its Asthma Program 8:19 a.m. Oct. 10, 2013 - Seeking Alpha
Some Speculative Biotechs Making Major Moves 12:36 p.m. Sept. 25, 2013 - Seeking Alpha
Data on Dynavax' Heplisav - Analyst Blog 11:00 a.m. Sept. 25, 2013 - Zacks.com
Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in VACCINE 2:01 p.m. Sept. 24, 2013 - benzinga.com

Board Appointments, Ratings Upgrade, Successful Deployments, Submissions, and Conferences - Research Report on Health Care REIT, Ventas, Masimo, Dynavax, and Magellan 8:00 a.m. Dec. 24, 2013 - PR Newswire
Dynavax Announces Submission of Responses to EMA Day 120 List of Questions for HEPLISAV(TM) MAA 9:01 a.m. Dec. 19, 2013 - Marketwire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax 8:00 a.m. Dec. 5, 2013 - PR Newswire
Dynavax Announces Resignation of J. Tyler Martin From Board of Directors 4:46 p.m. Nov. 27, 2013 - Marketwire
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:11 a.m. Nov. 25, 2013 - ACCESSWIRE
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Dynavax Reports Third Quarter 2013 Financial Results 5:10 p.m. Nov. 7, 2013 - Marketwire
Market Briefing: Emerging Growth NASDAQ Stocks in the News 2:22 p.m. Oct. 25, 2013 - PR Newswire
Dynavax Prices Public Offerings of Common Stock and Series B Convertible Preferred Stock 7:30 a.m. Oct. 25, 2013 - Marketwire
Dynavax Announces Proposed Public Offerings of Common Stock and Series B Convertible Preferred Stock 3:01 p.m. Oct. 24, 2013 - Marketwire
Pre-Market Review: Teva Pharma Industries Ltd, Dynavax Technologies Corp., Covidien PLC, and Valeant Pharma Intl. Inc. 8:39 a.m. Oct. 24, 2013 - PR Newswire
Dynavax Reports on HEPLISAV(TM) Regulatory Path 4:09 p.m. Oct. 16, 2013 - Marketwire
Dynavax Initiates First Human Trial in Asthma Program 4:46 p.m. Oct. 9, 2013 - Marketwire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 and Patients With Chronic Kidney Disease Published in VACCINE 3:00 p.m. Sept. 24, 2013 - Marketwire
Today's Research: Avanir Pharmaceuticals Inc., Warner Chilcott plc, Actavis Inc., and Dynavax Technologies Corp. 7:00 a.m. Aug. 28, 2013 - PR Newswire
Zeldes Haeggquist & Eck, LLP Announces Investigation of Dynavax Technologies Corporation 8:01 a.m. Aug. 16, 2013 - BusinessWire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Dynavax Technologies Corporation 9:54 p.m. Aug. 13, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Deadline of August 19, 2013 to Seek Lead Plaintiff Position 3:37 p.m. Aug. 12, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infotech's 2026 Report Crowns PSA Software Leaders

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

NORROY's Radiopharma Innovations: EANM Highlights

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

AlphaESS Secures Fifth Tier 1 Status Amid Growth

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

KT&G Soars with Record Profits, Aggressive Share Buybacks

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

SKF's Industrial Push: Energy Efficiency at COP31

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Magnolia Data Breach: Legal Stakes Loom for Seniors

Elderly Residents at Risk After Data Breach Well, here we go again — another day, another data breach debacle. This time, it's Magnolia Management putting senior residents' sensitive information on a silver platter for potential cyber intruders. We're talking names, Social Security numbers, and medical records — the whole shebang. When you're handling such crucial...

Multi-Society Panel Boosts Vaccine Guidance Clarity

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Bram Schot Steers Marelli Through Chapter 11 Resurgence

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...